Evidence map›Paper›PMID 38341557›Full record

ArticleClinical proteomics2024

Correction: Glial cell proteome using targeted quantitative methods for potential multi-diagnostic biomarkers.

Narae Kang, Hyun Jeong Oh, Ji Hye Hong, Hyo Eun Moon, Yona Kim, Hyeon-Jeong Lee, Hophil Min, Hyeonji Park, Sang Hun Lee, Sun Ha Paek and 1 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical proteomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Narae Kang *New Drug Development Center, Heungdeok-gu, Chungbuk, Cheongju-si, 28160, Korea.
Hyun Jeong Oh *School of Mechanical Engineering, Korea University, Seoul, 024841, Republic of Korea.
Ji Hye Hong *New Drug Development Center, Heungdeok-gu, Chungbuk, Cheongju-si, 28160, Korea.
Hyo Eun MoonDepartment of Neurosurgery, Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University, 28 Yeongeon-dong, Jongno-gu, Seoul, 03080, Korea.
Yona KimDepartment of Neurosurgery, Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University, 28 Yeongeon-dong, Jongno-gu, Seoul, 03080, Korea.
Hyeon-Jeong LeeDepartment of Molecular Medicine & Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 28 Yeongeon-dong, Jongno-gu, Seoul, 03080, Korea.
Hophil MinDoping Control Center, Korea Institute of Science and Technology, Hwarang-ro 14-gil, Seongbuk-gu, Seoul, 02792, Korea.
Hyeonji ParkNew Drug Development Center, Heungdeok-gu, Chungbuk, Cheongju-si, 28160, Korea.
Sang Hun LeeDepartment of Chemical and Biological Engineering, Hanbat National University, Daejeon, 34158, Korea.
Sun Ha Paek *Department of Neurosurgery, Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University, 28 Yeongeon-dong, Jongno-gu, Seoul, 03080, Korea. paeksh@snu.ac.kr.
Jonghwa Jin *New Drug Development Center, Heungdeok-gu, Chungbuk, Cheongju-si, 28160, Korea. jichang011@kbiohealth.kr.
Korea Institute of Science and Technology · KRSeoul National University · KRAdvanced Institute of Convergence Technology · KRHanbat National University · KRKorea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38341557
PMCPMC10858455
OpenAlexW4391718699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.